Clomipramine and neuroleptic malignant syndrome

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7494.790-c (Published 31 March 2005) Cite this as: BMJ 2005;330:790

Literature on adverse reactions to psychotropic drugs continues to confuse

  1. Geoffrey K Isbister (gsbite@ferntree.com), clinical toxicologist,
  2. Nicholas A Buckley, associate professor
  1. Newcastle Mater Misericordiae Hospital, Edith Street, Waratah, NSW 2298, Australia
  2. Clinical Pharmacology and Toxicology, Canberra Hospital, PO Box 11, Woden, ACT 2606, Australia

    EDITOR—Haddow et al describe a severe adverse drug reaction but create an oxymoron in describing clomipramine induced “neuroleptic malignant syndrome.”1

    Clomipramine is not a neuroleptic and therefore by definition cannot cause this syndrome (any more than it can cause anti-convulsant hypersensitivity syndrome). The description is consistent with serotonin toxicity, a well described adverse …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription